A detailed history of 360 Financial, Inc. transactions in Opko Health, Inc. stock. As of the latest transaction made, 360 Financial, Inc. holds 75,700 shares of OPK stock, worth $112,036. This represents 0.04% of its overall portfolio holdings.

Number of Shares
75,700
Previous 62,500 21.12%
Holding current value
$112,036
Previous $94,000 4.26%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.87 - $1.57 $11,484 - $20,724
13,200 Added 21.12%
75,700 $90,000
Q4 2023

Feb 13, 2024

BUY
$1.23 - $1.63 $9,028 - $11,964
7,340 Added 13.31%
62,500 $94,000
Q3 2023

Nov 14, 2023

SELL
$1.5 - $2.17 $2,700 - $3,906
-1,800 Reduced 3.16%
55,160 $88,000
Q2 2023

Aug 11, 2023

BUY
$1.37 - $2.17 $8,220 - $13,020
6,000 Added 11.77%
56,960 $123,000
Q1 2023

Apr 10, 2023

BUY
$1.06 - $1.61 $11,660 - $17,710
11,000 Added 27.53%
50,960 $74,000
Q3 2022

Oct 18, 2022

BUY
$1.81 - $2.81 $22,733 - $35,293
12,560 Added 45.84%
39,960 $76,000
Q2 2022

Aug 04, 2022

SELL
$2.33 - $3.61 $40,448 - $62,669
-17,360 Reduced 38.78%
27,400 $66,000
Q1 2022

Apr 11, 2022

BUY
$2.87 - $4.93 $5,740 - $9,860
2,000 Added 4.68%
44,760 $162,000
Q4 2021

Jan 18, 2022

BUY
$3.52 - $5.15 $29,216 - $42,745
8,300 Added 24.09%
42,760 $206,000
Q3 2021

Oct 13, 2021

BUY
$3.44 - $4.24 $6,192 - $7,632
1,800 Added 5.51%
34,460 $126,000
Q1 2021

Apr 28, 2021

BUY
$4.19 - $5.99 $10,558 - $15,094
2,520 Added 8.36%
32,660 $140,000
Q4 2020

Feb 09, 2021

BUY
$3.27 - $4.87 $915 - $1,363
280 Added 0.94%
30,140 $119,000
Q3 2020

Nov 09, 2020

BUY
$2.99 - $5.96 $3,306 - $6,591
1,106 Added 3.85%
29,860 $110,000
Q4 2019

Feb 28, 2020

BUY
$1.42 - $2.17 $40,830 - $62,396
28,754 New
28,754 $47,000

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.14B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track 360 Financial, Inc. Portfolio

Follow 360 Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 360 Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on 360 Financial, Inc. with notifications on news.